![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MFSD5 |
Gene summary for MFSD5 |
![]() |
Gene information | Species | Human | Gene symbol | MFSD5 | Gene ID | 84975 |
Gene name | major facilitator superfamily domain containing 5 | |
Gene Alias | SLC61A1 | |
Cytomap | 12q13.13 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q6N075 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84975 | MFSD5 | HTA11_3410_2000001011 | Human | Colorectum | AD | 4.69e-05 | 1.15e-01 | 0.0155 |
84975 | MFSD5 | HTA11_2487_2000001011 | Human | Colorectum | SER | 9.67e-08 | 3.16e-01 | -0.1808 |
84975 | MFSD5 | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.82e-10 | 3.48e-01 | -0.0811 |
84975 | MFSD5 | HTA11_347_2000001011 | Human | Colorectum | AD | 6.40e-18 | 3.25e-01 | -0.1954 |
84975 | MFSD5 | HTA11_411_2000001011 | Human | Colorectum | SER | 6.15e-07 | 7.77e-01 | -0.2602 |
84975 | MFSD5 | HTA11_3361_2000001011 | Human | Colorectum | AD | 8.04e-10 | 4.14e-01 | -0.1207 |
84975 | MFSD5 | HTA11_83_2000001011 | Human | Colorectum | SER | 1.83e-04 | 2.47e-01 | -0.1526 |
84975 | MFSD5 | HTA11_696_2000001011 | Human | Colorectum | AD | 5.56e-08 | 2.99e-01 | -0.1464 |
84975 | MFSD5 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.29e-07 | 2.51e-01 | -0.1001 |
84975 | MFSD5 | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.02e-11 | 3.86e-01 | -0.059 |
84975 | MFSD5 | HTA11_5212_2000001011 | Human | Colorectum | AD | 7.04e-06 | 3.39e-01 | -0.2061 |
84975 | MFSD5 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.06e-03 | 2.06e-01 | -0.0842 |
84975 | MFSD5 | HTA11_7862_2000001011 | Human | Colorectum | AD | 2.43e-06 | 3.15e-01 | -0.0179 |
84975 | MFSD5 | HTA11_866_3004761011 | Human | Colorectum | AD | 6.45e-10 | 3.27e-01 | 0.096 |
84975 | MFSD5 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.80e-02 | 1.31e-01 | 0.0338 |
84975 | MFSD5 | HTA11_7696_3000711011 | Human | Colorectum | AD | 8.32e-06 | 1.89e-01 | 0.0674 |
84975 | MFSD5 | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.84e-08 | 2.30e-01 | 0.0588 |
84975 | MFSD5 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.40e-04 | 2.27e-01 | 0.294 |
84975 | MFSD5 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 3.82e-14 | 3.92e-01 | 0.3859 |
84975 | MFSD5 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.14e-05 | 1.98e-01 | 0.3005 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0015698 | Colorectum | AD | inorganic anion transport | 52/3918 | 180/18723 | 6.83e-03 | 4.22e-02 | 52 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MFSD5 | SNV | Missense_Mutation | c.641N>A | p.Ser214Tyr | p.S214Y | Q6N075 | protein_coding | deleterious(0.03) | possibly_damaging(0.718) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MFSD5 | SNV | Missense_Mutation | novel | c.1595G>A | p.Gly532Glu | p.G532E | Q6N075 | protein_coding | tolerated(0.28) | benign(0.011) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MFSD5 | SNV | Missense_Mutation | novel | c.694N>G | p.Gln232Glu | p.Q232E | Q6N075 | protein_coding | tolerated(0.68) | benign(0.105) | TCGA-EY-A1GH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MFSD5 | SNV | Missense_Mutation | rs778394694 | c.1064G>A | p.Arg355His | p.R355H | Q6N075 | protein_coding | deleterious(0) | probably_damaging(0.931) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MFSD5 | SNV | Missense_Mutation | c.1211N>A | p.Ser404Tyr | p.S404Y | Q6N075 | protein_coding | deleterious(0.01) | possibly_damaging(0.718) | TCGA-BC-A10U-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
MFSD5 | SNV | Missense_Mutation | c.416C>T | p.Ala139Val | p.A139V | Q6N075 | protein_coding | tolerated(0.34) | benign(0.082) | TCGA-BC-A3KG-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
MFSD5 | SNV | Missense_Mutation | novel | c.865N>T | p.Ala289Ser | p.A289S | Q6N075 | protein_coding | tolerated(0.07) | possibly_damaging(0.616) | TCGA-DD-AACH-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
MFSD5 | SNV | Missense_Mutation | novel | c.380N>G | p.Glu127Gly | p.E127G | Q6N075 | protein_coding | deleterious(0.03) | benign(0.157) | TCGA-DD-AAW3-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MFSD5 | SNV | Missense_Mutation | novel | c.907N>G | p.Ile303Val | p.I303V | Q6N075 | protein_coding | deleterious(0.02) | benign(0.014) | TCGA-22-4593-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
MFSD5 | SNV | Missense_Mutation | novel | c.1268C>T | p.Ser423Phe | p.S423F | Q6N075 | protein_coding | tolerated(0.73) | probably_damaging(0.961) | TCGA-CN-5360-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |